RONNIE RAINES: Open Payments
NPI 1245328947 · CELINA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 21 payments from 11 companies in 2025. Trend: 2023 $515 · 2024 $300 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Corcept Therapeutics | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Indivior Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: VRAYLAR, UBRELVY, CAPLYTA, Korlym, HETLIOZ, Veozah, ELIQUIS, OTEZLA.
Industry payments across TN — which companies pay providers there.
